BeyondSpring Inc. Net Income (Loss) Attributable to Noncontrolling Interest
BeyondSpring Inc. (BYSI) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$115 for the 6-month period ending 2024-06-30, per its 6-K filed 2024-08-29.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2024-08-29
- BeyondSpring Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-12-31 was -$1.22M.
- BeyondSpring Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$1.77M.
- BeyondSpring Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$586.00K.
- BeyondSpring Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$455.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -$115.00 6-K · filed 2024-08-29 | ||||
| 2023-06-30 | -$541.00 6-K · filed 2024-08-29 | -$541.00K 6-K · filed 2024-02-02 | |||
| 2022-12-31 | -$3.00M 20-F · filed 2023-04-18 | ||||
| 2022-06-30 | -$1.68M 6-K · filed 2024-02-02 | ||||
| 2021-12-31 | -$1.22M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$2.99M derived: sum of 2 quarters · filed 2023-04-18 | -$3.57M derived: sum of 3 quarters · filed 2023-04-18 | -$4.03M 20-F · filed 2023-04-18 | |
| 2021-09-30 | -$1.77M 6-K · filed 2021-12-30 | -$2.36M derived: sum of 2 quarters · filed 2021-12-30 | -$2.81M 6-K · filed 2021-12-30 | -$3.59M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-06-30 | -$586.00K 6-K · filed 2021-09-10 | -$1.04M 6-K · filed 2023-02-28 | -$1.82M derived: sum of 3 quarters · filed 2023-04-18 | -$2.46M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-03-31 | -$455.00K 6-K · filed 2021-06-16 | -$1.24M derived: sum of 2 quarters · filed 2023-04-18 | -$1.88M derived: sum of 3 quarters · filed 2023-04-18 | -$2.73M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2020-12-31 | -$780.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | -$1.42M derived: sum of 2 quarters · filed 2023-04-18 | -$2.27M derived: sum of 3 quarters · filed 2023-04-18 | -$2.85M 20-F · filed 2023-04-18 | |
| 2020-09-30 | -$644.00K 6-K · filed 2021-12-30 | -$1.49M derived: sum of 2 quarters · filed 2021-12-30 | -$2.07M 6-K · filed 2021-12-30 | -$3.06M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-06-30 | -$846.00K 6-K · filed 2021-09-10 | -$1.42M 6-K · filed 2021-09-10 | -$2.41M derived: sum of 3 quarters · filed 2022-04-14 | -$2.87M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-03-31 | -$578.00K 6-K · filed 2021-06-16 | -$1.57M derived: sum of 2 quarters · filed 2022-04-14 | -$2.02M derived: sum of 3 quarters · filed 2022-04-14 | -$2.29M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2019-12-31 | -$989.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | -$1.45M derived: sum of 2 quarters · filed 2022-04-14 | -$1.71M derived: sum of 3 quarters · filed 2022-04-14 | -$2.25M 20-F · filed 2022-04-14 | |
| 2019-09-30 | -$457.00K 6-K · filed 2020-11-17 | -$725.00K derived: sum of 2 quarters · filed 2020-11-17 | -$1.26M 6-K · filed 2020-11-17 | -$1.85M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-06-30 | -$268.00K 6-K · filed 2020-09-03 | -$802.00K 6-K · filed 2020-09-03 | -$1.40M derived: sum of 3 quarters · filed 2021-04-30 | -$2.36M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-03-31 | -$534.00K 6-K · filed 2020-06-11 | -$1.13M derived: sum of 2 quarters · filed 2021-04-30 | -$2.09M derived: sum of 3 quarters · filed 2021-04-30 | -$2.71M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2018-12-31 | -$594.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | -$1.56M derived: sum of 2 quarters · filed 2021-04-30 | -$2.18M derived: sum of 3 quarters · filed 2021-04-30 | -$2.60M 20-F · filed 2021-04-30 | |
| 2018-09-30 | -$965.00K 6-K · filed 2019-12-18 | -$1.59M derived: sum of 2 quarters · filed 2019-12-18 | -$2.01M 6-K · filed 2019-12-18 | -$2.81M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-06-30 | -$621.00K 6-K · filed 2019-09-18 | -$1.05M 6-K · filed 2019-09-18 | -$1.84M derived: sum of 3 quarters · filed 2020-04-30 | -$3.82M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-03-31 | -$425.00K 6-K · filed 2019-07-10 | -$1.22M derived: sum of 2 quarters · filed 2020-04-30 | -$3.20M derived: sum of 3 quarters · filed 2020-04-30 | -$4.73M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2017-12-31 | -$797.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | -$2.77M derived: sum of 2 quarters · filed 2020-04-30 | -$4.31M derived: sum of 3 quarters · filed 2020-04-30 | -$4.63M 20-F · filed 2020-04-30 | |
| 2017-09-30 | -$1.98M 6-K · filed 2017-11-09 | -$3.51M derived: sum of 2 quarters · filed 2018-10-23 | -$3.83M 6-K · filed 2017-11-09 | -$3.98M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-06-30 | -$1.53M 6-K · filed 2018-10-23 | -$1.85M 6-K · filed 2018-10-23 | -$2.01M derived: sum of 3 quarters · filed 2019-04-30 | -$2.18M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-03-31 | -$316.00K 6-K · filed 2018-06-21 | -$472.00K derived: sum of 2 quarters · filed 2019-04-30 | -$647.00K derived: sum of 3 quarters · filed 2019-04-30 | -$785.00K derived: sum of 4 quarters · filed 2019-04-30 | |
| 2016-12-31 | -$156.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | -$331.00K derived: sum of 2 quarters · filed 2019-04-30 | -$469.00K derived: sum of 3 quarters · filed 2019-04-30 | -$535.00K 20-F · filed 2019-04-30 | |
| 2016-09-30 | -$175.00K 6-K · filed 2017-11-09 | -$313.00K derived: sum of 2 quarters · filed 2017-11-09 | -$379.00K 6-K · filed 2017-11-09 | ||
| 2016-06-30 | -$138.00K derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | -$203.00K 6-K · filed 2017-08-21 | |||
| 2016-03-31 | -$65.00K 6-K · filed 2017-05-22 | ||||
| 2015-12-31 | -$82.00K 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |